Broadridge Financial Solutions (NYSE:BR – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $231.00 to ...
Bioray Pharmaceutical Co. Ltd. has announced clinical trial clearance in China by the National Medical Products Administration (NMPA) for BR-111 for injection for the treatment of ROR1-positive ...
Broadridge Financial Solutions (NYSE:BR – Get Free Report) had its target price raised by research analysts at Royal Bank of Canada from $246.00 to $259.00 in a report issued on Monday,Benzinga ...